DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5012Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Karimov M., Sobirova G.,Ismailova J. | - |
| dc.date.accessioned | 2022-12-13T10:51:01Z | - |
| dc.date.available | 2022-12-13T10:51:01Z | - |
| dc.date.issued | 2022-12 | - |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/5012 | - |
| dc.description.abstract | The article presents the results of the anti-inflammatory efficacy of the new generation protease inhibitor ulinastatin in the treatment of exacerbation of chronic pancreatitis of moderate severity. It is shown that exacerbation of chronic pancreatitis of alimentary, alcoholic and biliary etiology was expressed by abdominal pain and dyspeptic symptoms. An increase in the level of serum aminotransferases, bilirubin and alpha amylase was noted, which was accompanied by a significant increase in the activity of pro-inflammatory cytokines. The use of ulinastatin in the complex of pharmacotherapy of chronic pancreatitis contributed to the effective relief of exacerbation of pancreatitis, which was due to the anticytokine effect of the drug. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Norwegian Journal of development of the International Science No 95/2022 | en_US |
| dc.relation.ispartofseries | УДК: 616.37-002.2(075.8); | - |
| dc.subject | chronic pancreatitis, ULINASTATIN, abdominal pain, dyspeptic symptoms | en_US |
| dc.title | THE EFFECTIVENESS OF ULINASTATIN IN PATIENTS WITH CHRONIC PANCREATITIS | en_US |
| dc.title.alternative | Norwegian Journal of development of the International Science No 95/2022 | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Tashkent Medical Academy Historical Books | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2. Собирова ГН Нор жур, 2022, 50-53.pdf | The article presents the results of the anti-inflammatory efficacy of the new generation protease inhibitor ulinastatin in the treatment of exacerbation of chronic pancreatitis of moderate severity. It is shown that exacerbation of chronic pancreatitis of alimentary, alcoholic and biliary etiology was expressed by abdominal pain and dyspeptic symptoms. An increase in the level of serum aminotransferases, bilirubin and alpha amylase was noted, which was accompanied by a significant increase in the activity of pro-inflammatory cytokines. The use of ulinastatin in the complex of pharmacotherapy of chronic pancreatitis contributed to the effective relief of exacerbation of pancreatitis, which was due to the anticytokine effect of the drug. | 871.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.